FDA Inspection 999592 — Anne Vekhoff

Anne Vekhoff — FEI 3012988308

The FDA completed an inspection of Anne Vekhoff on January 19, 2017 in Paris CEDEX 12. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 19, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Paris CEDEX 12 (France)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753121 CFR 312.62(c)Record retention